Our latest News & Events
Life Sciences Review: Atessia: Tailor-made solutions for Pharmaceutical Regulatory Changes 🇬🇧
We are happy to share that ATESSIA, Life Science Advisors was selected by Life Sciences Review among the top 10 regulatory consulting firms in Europe for 2022.
The mysterious thing that an Exploitant is
French always do it different In many domains, French people like to stand out, either in a positive or negative way. In the Healthcare field,
Registering gene therapy medicinal products
The regulatory requirements for the pharmaceutical development of gene therapy medicinal product are described in Annex I, part IV of Directive 2001/83/EC applied to advanced
How to manage a non-GMP raw material in your MA files?
French always do it different In many domains, French people like to stand out, either in a positive or negative way. In the Healthcare field,
How to proceed with non-pharmacopoeial excipients in the formulation of a medicinal product for human use?
French always do it different In many domains, French people like to stand out, either in a positive or negative way. In the Healthcare field,
Advertising for medicines: the keys to obtaining a visa in France
French always do it different In many domains, French people like to stand out, either in a positive or negative way. In the Healthcare field,
Do “over the counter” medicines exist in France?
French always do it different In many domains, French people like to stand out, either in a positive or negative way. In the Healthcare field,
The French version of the former anti-gift law
France is known for its strict regulatory provisions when it comes to medicines. The exception will not be made for the framework of relations between
LunchWork Atessia 11/05/22 “Nitrosamines: Final stretch to meet the deadlines”
On Wednesday 11 May 2022, our 4th Lunchwork of the year took place on the theme of nitrosamine impurities for which the regulatory deadlines are